(UroToday.com) Clinical stage 1 testicular cancer is managed surgically, with cancer-specific survival rates approaching 100%. Risk factors for recurrence vary by histology and include the size of the tumor (seminoma) and presence of lymphovascular invasion and degree of embryonal carcinoma predominance (non-seminoma). In this poster, Dr. Rohit Badia and colleagues investigated the utility of pre-orchiectomy serum tumor markers in predicting the recurrence of stage 1 testicular cancer.